XML 23 R11.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Fair value of financial instruments
6 Months Ended
Jun. 30, 2024
Fair value of financial instruments  
Fair value of financial instruments

(4) Fair value of financial instruments

The Company measures the following financial liabilities at fair value on a recurring basis. There were no transfers between levels of the fair value hierarchy during any of the periods presented.

The following tables set forth the Company’s financial assets and liabilities carried at fair value categorized using the lowest level of input applicable to each financial instrument as of June 30, 2024 and December 31, 2023:

Quoted Prices

in Active

Significant

Markets for

Other

Significant

Balance at

Identical

Observable

Unobservable

June 30, 

Assets

Inputs

Inputs

    

2024

    

(Level 1)

    

(Level 2)

    

(Level 3)

Assets:

Cash equivalents

$

6,540

$

6,540

$

$

U.S Treasury securities

25,897

25,897

Corporate bonds

3,463

3,463

U.S. Government agency bonds

3,496

3,496

Commercial paper

3,455

3,455

Yankee bonds

3,486

3,486

Total Assets

$

46,337

$

6,540

$

39,797

$

Liabilities:

 

  

 

  

 

  

 

  

Contingent consideration – Short term portion

$

1,935

$

$

$

1,935

Contingent consideration – Long term portion

4,097

4,097

Total Liabilities

$

6,032

$

$

$

6,032

Quoted Prices

in Active

Significant

Markets for

Other

Significant

Balance at

Identical

Observable

Unobservable

 

December 31, 

 

Assets

 

Inputs

 

Inputs

    

2023

    

(Level 1)

    

(Level 2)

    

(Level 3)

Assets:

Cash equivalents

$

76,844

$

76,844

$

$

Total Assets

$

76,844

$

76,844

$

$

Liabilities:

 

  

 

  

 

  

 

  

Contingent consideration – Short term portion

$

1,911

$

$

$

1,911

Contingent consideration – Long term portion

5,765

5,765

Total Liabilities

$

7,676

$

$

$

7,676

The following is a summary of cash equivalents and marketable securities as of June 30, 2024 and December 31, 2023:

June 30, 2024

Gross

Gross

Unrealized

Unrealized

Estimated

    

Cost

    

Gains

    

Losses

    

Fair Value

Cash equivalents

$

6,540

$

$

$

6,540

Marketable securities (due in one year or less):

U.S Treasury securities

25,897

25,897

Corporate bonds

3,469

(6)

3,463

Commercial paper

3,458

(3)

3,455

Yankee bonds

3,487

(1)

3,486

Total marketable securities due in one year or less

36,311

(10)

36,301

Marketable securities (due in one to two years):

U.S. Government agency bonds

3,498

(2)

3,496

Total marketable securities due in one to two years

3,498

(2)

3,496

Total cash equivalents and marketable securities

$

46,349

$

$

(12)

$

46,337

December 31, 2023

Gross

Gross

Unrealized

Unrealized

Estimated

    

Cost

    

Gains

    

Losses

    

Fair Value

Cash equivalents

$

76,844

$

$

$

76,844

Total cash equivalents

$

76,844

$

$

$

76,844

The Company held six debt securities at June 30, 2024 classified as marketable securities with original maturity dates greater than three months that were in an unrealized loss position for less than twelve months. The fair market value of these securities was $24,147. The Company evaluated its securities for other-than-temporary impairments based on quantitative and qualitative factors. The Company considered the decline in market value for these securities to be primarily attributable to current economic and market conditions. It is not more likely than not that the Company will be required to sell these securities, and the Company does not intend to sell these securities before the recovery of their amortized cost basis. Based on its analysis, the Company does not consider these investments to be other-than-temporarily impaired as of June 30, 2024.

The Company had no material realized gains or losses on its available-for-sale securities for the three and six months ended June 30, 2024 and 2023.

The Company’s recurring fair value measurements using Level 3 inputs relate to the Company’s contingent consideration liability. In those circumstances where an acquisition involves a contingent consideration arrangement, the Company recognizes a liability equal to the fair value of the contingent payments the Company expects to make as of the acquisition date. The Company re-measures this liability each reporting period and records changes in the fair value through changes in fair value of contingent consideration on the Company’s consolidated statements of operations. Increases or decreases in the fair value of the contingent consideration liability can result from changes in discount rates, periods, timing and amount of projected revenue.

The recurring Level 3 fair value measurements of the Company’s contingent consideration liability include the following significant unobservable inputs:

Fair Value

  

  

as of

June 30, 

Valuation

Unobservable

Contingent Consideration Liability

    

2024

    

Technique

    

Inputs

Revenue-based Payments

$

6,032

 

Discounted Cash Flow Analysis under the Income Approach

 

Revenue discount factor, discount rate